These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410 [TBL] [Abstract][Full Text] [Related]
5. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Varoquaux A; Rager O; Poncet A; Delattre BM; Ratib O; Becker CD; Dulguerov P; Dulguerov N; Zaidi H; Becker M Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):462-75. PubMed ID: 24108458 [TBL] [Abstract][Full Text] [Related]
6. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study. Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188 [TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
8. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
9. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma. Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897 [TBL] [Abstract][Full Text] [Related]
10. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
11. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152 [TBL] [Abstract][Full Text] [Related]
13. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
14. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT. Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644 [TBL] [Abstract][Full Text] [Related]
15. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer. Platzek I PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244 [TBL] [Abstract][Full Text] [Related]
16. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207 [TBL] [Abstract][Full Text] [Related]
17. FDG PET/MR for lymph node staging in head and neck cancer. Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792 [TBL] [Abstract][Full Text] [Related]
18. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956 [TBL] [Abstract][Full Text] [Related]
19. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264 [TBL] [Abstract][Full Text] [Related]